Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
eczema
Pharma
In year 2 under new CEO, troubled Leo Pharma makes progress
Leo its touting progress on its turnaround. The 115-year-old company cut its operating costs by 14% in 2023 while increasing its revenues by 7%.
Kevin Dunleavy
Mar 12, 2024 1:47pm
Leo Pharma builds its case for JAK inhibitor cream delgocitinib
Jan 24, 2024 10:36am
Dermavant CEO draws Botox comparison to instill Vtama confidence
Nov 28, 2023 4:10pm
Incyte taps actor to help tell the stories of eczema patients
Oct 12, 2023 11:38am
Dermavant strengthens approval bid for Vtama in eczema
Oct 12, 2023 8:50am
Incyte's Opzelura hits goal in eczema trial in young kids
Jul 12, 2023 10:30am